Compared to the historical benchmark, pelareorep-atezolizumab nearly tripled ORR Combination achieved encouraging median DOR ...
Clene is scheduled to meet with the FDA in the coming months to discuss new data for CNM-Au8, its experimental oral therapy ...
SAN FRANCISCO, CA, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Avinasi Labs, an AI-native longevity infrastructure company building the world’s first liquid foundation model for ageing ...
Pills that work similarly to currently available injectable medications represent the next wave of metabolic disorder drugs, and Viking Therapeutics is pushing its drug candidate to the forefront with ...
Penn Medicine links EHR with real-time care data to study clinician-patient interactions and improve clinical practice using multimodal datasets.
The research has generated significant interest from firms in food & as consumers seek natural alternatives to GLP-1 drugs.
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Vizient® is proud to announce that the Vizient Clinical Data Base was recognized by Modern Healthcare as one of the Best in ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback